Invenomic Capital Management’s Douglas Emmett DEI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-138,177
Closed -$2.17M 152
2022
Q4
$2.17M Sell
138,177
-7,278
-5% -$121K 0.15% 119
2022
Q3
$2.61M Buy
+145,455
New +$3.1M 0.22% 107

Other funds holding DEI

Invenomic Capital Management's DEI Position: Q1 2023 in Review

Invenomic Capital Management sold out of Douglas Emmett (DEI) in Q1 2023, closing a stake of 138,177 shares — an estimated $2.17M sold.

Invenomic Capital Management first reported a position in DEI in Q3 2022 and held it in 2 quarters. The position peaked at $2.61M in Q3 2022. 259 funds tracked by Wall St. Rank hold DEI as of Q1 2023.

  • Invenomic Capital Management reported no remaining Douglas Emmett position as of Q1 2023 after selling out during the quarter.
  • Invenomic Capital Management sold 138,177 Douglas Emmett shares in Q1 2023, an estimated $2.17M.
  • Invenomic Capital Management first reported a position in Douglas Emmett in Q3 2022 and held it in 2 quarters.
  • Invenomic Capital Management's Douglas Emmett position peaked at $2.61M in Q3 2022.
  • 259 funds tracked by Wall St. Rank held Douglas Emmett as of Q1 2023.

Based on Invenomic Capital Management's 13F filing for Q1 2023, filed 15 May 2023.